Transition Bio Closes $50 Million Series A Financing to Accelerate Biomolecular Condensate Drug Discovery

Transition Bio, Inc., a microfluidics- driven drug discovery platform company Read More ⟶

By |2022-06-02T13:39:40+00:00May 29, 2022|Uncategorized|0 Comments
Read More

Bringing droplet microfluidics and machine learning together for novel drug discovery.

Follow Us

 

United States
100 Talcott Avenue
Watertown
MA 02472

United Kingdom
Eastbrook
Shaftesbury Road
Cambridge
CB2 8DU

© Transition Bio, LLC. All rights reserved. No part of this website may be used or reproduced, without prior written permission. Web Site design and build by Graham Relf Design.

Go to Top